BD Rx Inc, announced that the FDA has approved metoclopramide hydrochloride, an injectable antiemetic, as the second drug to be offered in the recently launched BD Simplist line of ready-to-administer prefilled generic injectables.
BD Simplist prefilled injectables are designed to help improve patient care and safety by decreasing the number of steps in the traditional vial and syringe injection sequence to approximately 12 steps, reducing the potential risk of medication error.
Metoclopramide hydrochloride is indicated for the relief of symptoms associated with acute and recurrent diabetic gastric stress, prophylaxis of vomiting associated with emetogenic cancer chemotherapy, and the prophylaxis of postoperative nausea and vomiting in those circumstances where nasogastric suction is undesirable. ■
